InvestorWire NewsRoom

Press Release

The MDMA Conference: A Molecular Masterclass Presents a Scientific Deep Dive into the Field of MDMA Therapeutics
June 14, 2021

The MDMA Conference: A Molecular Masterclass Presents a Scientific Deep Dive into the Field of MDMA Therapeutics

NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) — via NetworkNewsWire –Microdose Psychedelic Insights, a cutting-edge conference production company focused around promoting content, financial analysis, and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, in partnership with Pharmala Biotech Inc and ACS Pharmacology & Translational Science, will be hosting the upcoming MDMA Conference: A Molecular Masterclass in an entirely virtual format on June 15, 2021. Ranging from exploring the cultural implications of MDMA through to its clinical applications, the conference will seek to educate attendees on the potential uses and benefits attached to MDMA in a clinical environment.

The event, which will present a scientific deep dive into the dynamic field of MDMA therapeutics, will explore the potential of MDMA at the intersection of drug development & safety, clinical care and applications, law & regulation, business & markets, science & research as well as history & culture.

This year’s event will feature a series of six keynote presentations and discussion panels, to be held over the course of the one-day event. Presentation topics will include, “MDMA-Assisted Psychotherapy for Treating Alcohol Use Disorder” by Dr Ben Sessa; “The Culture of MDMA: The Go-To Medicine in America’s Future” delivered by psychotherapist and author Charles Wininger; “Business, Markets & Regulation” presented by CannDelta Inc, MicroDose, Santis Health, Mindcure and Psyched Wellness; “Public attitudes towards Psychedelics in Canada” by Abacus Data and spark*advocacy; “MDMA & Clinical Applications” as well as “Harm Reduction”. Furthermore, the conference will also play host to a keynote address my Rick Doblin, Ph.D., the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).

The conference will seek to enable attendees to build relationships, network with professionals from across the MDMA and psychedelics industry and gain access to exciting and ground-breaking pre-IPO investment opportunities within the wider sector.

Additional information about the MDMA Conference, as well as details for registration, can be found on the MDMA Conference website at

About Microdose Psychedelic Insights:

Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine.

Microdose Psychedelic Insights
[email protected] 

Media Contact: 
InvestorBrandNetwork (IBN) 
Los Angeles, California 
310.299.1717 Office 
[email protected] 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).